AMRX PDUFA decision: a positive outcome, +5.2%

On May 15, 2023, Amneal Pharmaceuticals, Inc. reached its PDUFA decision. The result was a positive outcome, and the stock moved +5.2% in the window around the event. It had already run +41.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.